Nirmatrelvir: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nirmatrelvir. Educational only — not medical advice.
Labeled uses
PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
Source: FDA labeling via NIH DailyMed (set 8a99d6d6…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.